IP Library Granted Patent US 8,617,612
Granted Patent B2
US 8,617,612 · App. 13/395,937 · Granted Dec 31, 2013

Granulated material mixture comprising two different granulated materials for artificial callus distraction

Inventor: Domonkos Horvath (Jestetten, DE)
Assignee: Celgen AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,617,612
App. No.
13/395,937
Granted
Dec 31, 2013
Kind
B2
Abstract

A granulate mixture suitable for regenerating a bone contains at least one expandable particle and at least one nondeformable particle. The at least one expandable particle contains a swelling agent. The swelling is enclosed by a biodegradable sheathing or be a biodegradable casing. Three-dimensional callus distraction may be accomplished by introducing the granulated mixture into a bone defect.

Claims (29)

1. A granulate mixture suitable for regenerating a bone comprising:

at least one non-deformable particle;

at least one expandable particle, the at least one expandable particle includes a swelling agent; and

a biodegradable sheathing enclosing the swelling agent.

2. The granulate mixture according to claim 1 , wherein the at least one non-deformable particle includes a plurality of non-deformable particles and wherein the at least one expandable particle includes a plurality of expandable particles.

3. The granulate mixture according to claim 1 , wherein a mixing ratio of the expandable particles to the non-deformable particles in the granulate mixture is 1:99 to 99:1, relative to the number of particles.

4. The granulate mixture according to claim 1 , wherein the swelling agent is a hydrogel.

5. The granulate mixture according to claim 1 , wherein the swelling agent expands as the result of absorption of a liquid selected from a group consisting of: a liquid containing biomolecules, cells, and a combination thereof.

6. The granulate mixture according to claim 5 , wherein the liquid is blood.

7. The granulate mixture according to claim 1 , wherein the swelling agent for the at least one expandable particle is composed of a polysaccharide.

8. The granulate mixture according to claim 1 , wherein the swelling agent for the at least one expandable particle is composed of a glucosamine.

9. The granulate mixture according to claim 1 , wherein the at least one expandable particle has a particle size of 0.0001 mm to 10 mm.

10. The granulate mixture according to claim 1 , wherein the at least one expandable particle has a particle size of 0.1 mm to 10 mm.

11. The granulate mixture according to claim 1 , wherein the particles of the plurality of expandable particles are present in at least two different particle sizes.

12. The granulate mixture according to claim 1 , wherein the at least one non-deformable particle contains a bone replacement material.

13. The granulate mixture according to claim 1 , wherein the at least one non-deformable particle contains hydroxyapatite and/or tricalcium phosphate.

14. The granulate mixture according to claim 1 , wherein the at least one non-deformable particle has a particle size of 0.01 mm to 10 mm.

15. The granulate mixture according to claim 1 , wherein the at least one non-deformable particle has a particle size of 0.1 mm to 10 mm.

16. The granulate mixture according to claim 1 , wherein the at least one non-deformable particle is not expandable or is not contractible.

17. The granulate mixture according to claim 1 , wherein the biodegradable sheathing encloses the swelling agent and the at least one non-deformable particle is outside the biodegradable casing when the biodegradable sheathing encloses the swelling agent.

18. The granulate mixture according to claim 17 , wherein the biodegradable sheathing is made of gelatin.

19. A granulate mixture suitable for regenerating a bone, the granulate mixture comprising:

at least one non-deformable particle;

at least one expandable particle, the at least one expandable particle including a swelling agent; and

a biodegradable sheathing enclosing the at least one expandable particle.

20. The granulate mixture according to claim 19 , wherein the granulate mixture including the biodegradable sheathing that is injectable into a bone defect.

21. The granulate mixture according to claim 20 , wherein the non-deformable particle is outside the biodegradable sheathing.

22. The granulate mixture according to claim 19 , wherein the at least one expandable particle increases in volume when in contact with a liquid.

23. The granulate mixture according to claim 22 , wherein the biodegradable sheathing prevents contact between the at least one expandable particle and the liquid until the biodegradable sheathing degrades.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2014
From: CELGEN AG
To: CELGEN3D AG
Reel/Frame 032815/0667 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2012
From: HORVATH, DOMONKOS
To: CELGEN AG
Reel/Frame 028091/0177 →
Priority Claims (1)
DE 10 2009 042 493 · Sep 14, 2009 · national
Continuity (1)
Related Publication 20120171293A1 · Jul 5, 2012